SUCLG1 — Succinate-CoA Ligase GDP Forming Subunit Alpha

SUCLG1 — Succinate-CoA Ligase GDP Forming Subunit Alpha

Overview

SUCLG1 (Succinate-CoA Ligase GDP Forming Subunit Alpha) encodes the alpha subunit of succinyl-CoA synthetase (SCS), also known as succinate-CoA ligase, which catalyzes a critical step in the tricarboxylic acid (TCA) cycle. This enzyme is unique among TCA cycle enzymes as the only one that directly produces nucleoside triphosphates—specifically GTP in the GDP-forming isoform. SUCLG1 forms a heterodimer with either SUCLG2 (to create the GTP-forming enzyme) or SUCLA2 (to create the ATP-forming enzyme), and together these enzymes sit at the intersection of cellular energy metabolism, nucleotide synthesis, and mitochondrial function.

SUCLG1 — Succinate-CoA Ligase GDP Forming Subunit Alpha

Overview

SUCLG1 (Succinate-CoA Ligase GDP Forming Subunit Alpha) encodes the alpha subunit of succinyl-CoA synthetase (SCS), also known as succinate-CoA ligase, which catalyzes a critical step in the tricarboxylic acid (TCA) cycle. This enzyme is unique among TCA cycle enzymes as the only one that directly produces nucleoside triphosphates—specifically GTP in the GDP-forming isoform. SUCLG1 forms a heterodimer with either SUCLG2 (to create the GTP-forming enzyme) or SUCLA2 (to create the ATP-forming enzyme), and together these enzymes sit at the intersection of cellular energy metabolism, nucleotide synthesis, and mitochondrial function.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Succinyl-CoA Synthetase (SCS)</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SUCLG1</td></tr>
<tr><td><strong>Protein Name</strong></td><td>Succinate-CoA ligase [GDP-forming] subunit alpha</td></tr>
<tr><td><strong>Chromosome</strong></td><td>2p11.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[26002](https://www.ncbi.nlm.nih.gov/gene/26002)</td></tr>
<tr><td><strong>OMIM</strong></td><td>605172</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000153558</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P53567](https://www.uniprot.org/uniprot/P53567)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Succinate-CoA ligase family</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Mitochondrial matrix</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Mitochondrial DNA Depletion Syndrome, Encephalomyopathy, Cardiomyopathy, Alzheimer's Disease</td></tr>
</table>
</div>

Gene Structure and Evolution

Genomic Organization

The SUCLG1 gene is located on chromosome 2 (2p11.2), spanning approximately 35 kb of genomic DNA. The gene consists of 13 exons that encode a protein of 463 amino acids with a molecular weight of ~50 kDa. The genomic structure is evolutionarily conserved, reflecting the fundamental importance of this enzyme in cellular metabolism.

The SUCLG1 promoter contains regulatory elements for mitochondrial biogenesis (PGC-1α response elements) and stress-dependent regulation (FOXO binding sites).

Evolutionary Conservation

SUCLG1 shows remarkable evolutionary conservation:

• Mammalian orthologs share >95% amino acid identity
• Vertebrate orthologs retain full enzymatic activity
• The catalytic domain is highly conserved

Protein Structure and Function

Domain Architecture

SUCLG1 contains several functional domains:

Catalytic Mechanism

Succinyl-CoA synthetase catalyzes the reversible reaction:

Succinyl-CoA + GDP + Pi ⇌ Succinate + GTP + CoA

The reaction proceeds through a thioester intermediate:

Enzyme Properties

| Property | Value |
|----------|-------|
| Molecular weight | 50 kDa (α subunit) |
| Subunit composition | αβ heterodimer |
| GTP-forming isoform | SUCLG1 + SUCLG2 |
| ATP-forming isoform | SUCLG1 + SUCLA2 |

Isoform Specificity

Two distinct isoforms exist:

GTP-forming (SUCLG1 + SUCLG2):

• Predominant in brain and heart
• Produces GTP for protein synthesis
• Important for mitochondrial translation

• Predominant in liver and kidney
• Produces ATP for cellular energy
• Important for overall metabolism

Expression and Localization

Tissue Distribution

SUCLG1 shows ubiquitous expression with tissue-specific patterns:

High expression:

• Brain: Cortex, hippocampus, cerebellum, basal ganglia
• Heart: Cardiac muscle (high energy demand)
• Liver: Hepatocytes (metabolic hub)
• Kidney: Tubular cells

Subcellular Localization

SUCLG1 localizes exclusively to the mitochondrial matrix:

• Import: Processed from precursor in cytosol
• Assembly: Forms heterodimers in matrix

Brain Expression Patterns

Within the central nervous system:

• Neurons: High expression in pyramidal neurons
• Glial cells: Moderate in astrocytes, high in oligodendrocytes

Role in Neurodegeneration

Mitochondrial Function in Neurons

Succinyl-CoA synthetase is critical for neuronal health:

Neurons are particularly dependent on SUCLG1 because:

• High energy requirements for synaptic function
• GTP needed for mitochondrial protein synthesis

Alzheimer's Disease (AD)

SUCLG1 dysfunction contributes to AD pathogenesis:

Energy metabolism impairment:

• SCS activity reduced in AD brain
• Impaired GTP production affects neuronal signaling

• SUCLG1 mutations cause mtDNA depletion
• mtDNA copy number altered in AD

Mitochondrial DNA Depletion Syndrome (MTDPS)

SUCLG1 mutations cause severe mitochondrial disease:

Disease phenotypes:

• Encephalomyopathy: Progressive neurological decline
• Cardiomyopathy: Heart failure
• Liver dysfunction: Hepatic failure

• mtDNA depletion: Reduced copy number
• Impaired mtDNA maintenance

Interaction Network

Protein-Protein Interactions

SUCLG1 interacts with:

Enzyme complex:

• SUCLG2: GTP-forming β subunit
• SUCLA2: ATP-forming β subunit

• Citrate synthase: TCA cycle partner
• Alpha-ketoglutarate dehydrogenase: TCA cycle partner
• Succinate dehydrogenase: TCA cycle partner

Signaling Pathway Integration

SUCLG1 integrates with:

Therapeutic Implications

Metabolic Modulation

Targeting SUCLG1 for therapeutic benefit:

Direct approaches:

• SCS activators: Enhance enzyme activity
• GTP precursors: Support nucleotide synthesis

• Mitochondrial cocktails: Support overall function
• PPAR agonists: Enhance mitochondrial biogenesis

Clinical Applications

• Alzheimer's disease: Improve neuronal metabolism
• Mitochondrial disease: Direct treatment
• Aging: Maintain mitochondrial function

Animal Models

Knockout Mouse

Suclg1 knockout mice are embryonic lethal:

• Die around embryonic day 10-12
• Severe developmental defects

Heterozygous Models

Suclg1⁺/⁻ mice:

• Partial enzyme reduction
• Mitochondrial dysfunction

Cross-Links

SUCLG1 connects to multiple NeuroWiki pages:

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Mitochondrial DNA Depletion Syndrome](/diseases/mitochondrial-dna-depletion)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
• [Tricarboxylic Acid Cycle](/mechanisms/tricarboxylic-acid-cycle)
• [Energy Metabolism](/mechanisms/energy-metabolism)
• [SUCLG2 Gene](/genes/suclg2)
• [SUCLA2 Gene](/genes/sucla2)

References

Appendix: Clinical and Research Resources

Diagnostic Testing

SUCLG1 genetic testing:

• Clinical testing: Available for mitochondrial disease
• Research testing: Functional assays

Therapeutic Pipeline

Current development status:

• Preclinical: Metabolic modulators
• Gene therapy: Preclinical development

Research Tools

Available resources:

• Antibodies: Validated commercial antibodies
• Mouse models: Knockout and transgenic lines

Pathway Diagram

The following diagram shows the key molecular relationships involving SUCLG1 — Succinate-CoA Ligase GDP Forming Subunit Alpha discovered through SciDEX knowledge graph analysis: